Investors NYSE MKT: LCTX Copyright West LLC. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases January 02, 2020 Lineage Cell Therapeutics Conducts Sale of Shares in OncoCyte Corporation December 30, 2019 Lineage Provides Update on Patient Enrollment in Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration December 24, 2019 Lineage Cell Therapeutics Enters Into Three Separate License Agreements for Certain Intellectual Property and Assets VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics at Solebury Trout’s KOL Event Nov 15, 2019 at 11:00 AM EST Q3 2019 Lineage Cell Therapeutics Earnings Conference Call Nov 12, 2019 at 1:30 PM PST Lineage Cell Therapeutics at Dawson James Securities 5th Annual Small Cap Growth Conference Oct 29, 2019 at 4:05 PM EDT VIEW EVENTS & PRESENTATIONS
December 30, 2019 Lineage Provides Update on Patient Enrollment in Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration
December 24, 2019 Lineage Cell Therapeutics Enters Into Three Separate License Agreements for Certain Intellectual Property and Assets
Lineage Cell Therapeutics at Dawson James Securities 5th Annual Small Cap Growth Conference Oct 29, 2019 at 4:05 PM EDT
